Option chain shows key data for Blueberries Medical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Blueberries Medical.

Blueberries Medical (OTC:BBRRF) Stock, Option Chain

Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.

cananbis debt (geralt and Kindel Media by Pixabay)(61)

Cannabis

News

Financing

ALID

BBRRF

CSE:BBM

Blueberries Medical, a Latin American licensed producer of medicinal cannabis and cannabis-derived products, has announced a non-brokered private placement, to raise approximately CA$1.9m ($1.4m). The company announced the sale of 180,716,00 common shares at CA$0.011 per share. The net proceeds from the sale will be used to repay existing debt and for general corporate and working capital purposes. The offering was led by Terraflos, a Latin American company founded and controlled by Facundo Garreton, who serves as Blueberries&#39; chairman, CEO, and director. Terraflos is exploring opportunities in Argentina, Mexico, and Brazil and plans to expand into those markets in the near future. 

Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal

Penny Stocks

Markets

Allied Corp. (OTCQB: ALID), a cannabis cultivator based in Colombia and one of the few to have executed on international exports, announced that it has signed a joint venture agreement with Blueberries Medical Corp. (OTCQB: 

Allied Corp Teams Up With Blueberries Medical To Produce Psychoactive And Non-Psychoactive Derivatives

Earnings

Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) released its financial results for the quarter ended on June 30, 2022, revealing total revenue of CA$39,826, an increase of CA$25,041 (or 169%) compared to Q2 2021.

Blueberries Medical Q2 Revenue Grows 169%, What About Net Loss?

BLUEBERRIES MEDICAL CO by Blueberries Medical Co.

Comments

Blueberries Medical

Blueberries Medical (BBRRF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell